ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹135 Cr | ₹124 Cr | ₹165 Cr | ₹222 Cr | ₹442 Cr |
What is the latest Total Non-Current Liabilities ratio of ORCHID PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹135 Cr |
| Mar2024 | ₹124 Cr |
| Mar2023 | ₹165 Cr |
| Mar2022 | ₹222 Cr |
| Mar2021 | ₹442 Cr |
How is Total Non-Current Liabilities of ORCHID PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹135 Cr | 8.46 | |
| Mar2024 | ₹124 Cr | -24.43 | |
| Mar2023 | ₹165 Cr | -25.96 | |
| Mar2022 | ₹222 Cr | -49.71 | |
| Mar2021 | ₹442 Cr | - | |
Compare Total Non-Current Liabilities of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹3,753.1 Cr | -2.3% | -10% | -60.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,019.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,752.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,542.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹115,883.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,024.7 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -2.3% |
-10% |
-60.3% |
| SENSEX | -1.9% |
-2.2% |
7.4% |
You may also like the below Video Courses